The National Headache Foundation applauds the approval and release of Teva Pharmaceutical's migraine preventive medication, Ajovy (fremenazumab), on Friday, September 14, 2018. This medication is the second in a new class of migraine preventers called CGRP monoclonal antibodies to be approved in 2018, with another...
June 28 is recognized as Headache Disease Research Day, and in 2018 headache and migraine patients have more to be excited about than ever. After decades of advocacy, education and research, the number and quality of new treatments and prevention methods available and currently in-research...
WGN Radio interviewed Dr. Timothy Smith, vice president of the National Headache Foundation, about the groundbreaking new migraine drug, Aimovig. You can listen to the entire show here....
Cold and flu season has returned like clockwork. As you hit the over-the-counter aisle, rummage through your medicine cabinet at home, and prepare to combat your family’s runny noses and sore throats, remember to double check medicine labels so you don’t accidentally double up on...
It’s that time of year again: cold and flu season is here. As you stock your medicine cabinet to combat coughs and stuffy noses, remember to double check your medicine labels so you don’t double up on medicines containing acetaminophen. Acetaminophen is the most common...